SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 8th, 2020 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 8th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement, dated as of January 7, 2020 (the “Agreement”), is by and between Tyme Technologies, Inc., a Delaware corporation with its principal offices at 17 State Street, 7th Floor, New York, NY 10004 (the “Company”), and Eagle Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ 07677 (the “Purchaser”).